Alzinova AB
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study on the Safety, Tolerability and Immunogenicity of ALZ-101 in Participants With Early Alzheimer's Disease (NCT05328115) | Alzinova AB | 2021-09-30 |
Track Alzinova AB automatically
Every clearance here is in the API, with alerts when new ones post.